Dr. Scott disclosed he is an Advisor for Exelixis and QED and receives Research Funds from Exelixis, Genentech, Incyte and Merck. All other Faculty, CME Planning Committee Members, and the CME Office Reviewers have disclosed that they do not have any relevant financial relationships with commercial interest that would constitute a conflict of interest concerning this CME activity.